• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Could the COVID-19 pandemic aggravate antimicrobial resistance?

作者信息

Rossato Luana, Negrão Fábio Juliano, Simionatto Simone

机构信息

Federal University of Grande Dourados-UFGD, Dourados, Mato Grosso do Sul, Brazil.

Federal University of Grande Dourados-UFGD, Dourados, Mato Grosso do Sul, Brazil.

出版信息

Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.

DOI:10.1016/j.ajic.2020.06.192
PMID:32603851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7320258/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a4/7320258/aa8c8ce6c6f7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a4/7320258/aa8c8ce6c6f7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14a4/7320258/aa8c8ce6c6f7/gr1_lrg.jpg

相似文献

1
Could the COVID-19 pandemic aggravate antimicrobial resistance?新冠疫情会加剧抗菌药物耐药性吗？
Am J Infect Control. 2020 Sep;48(9):1129-1130. doi: 10.1016/j.ajic.2020.06.192. Epub 2020 Jun 27.
2
Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?2019年冠状病毒病疫情的附带损害：抗菌药物耐药性加剧及抗菌药物管理计划受到干扰？
S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.
3
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
4
Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options.新冠肺炎阳性患者的真菌感染：缺乏最佳治疗方案
Curr Top Med Chem. 2020;20(22):1951-1957. doi: 10.2174/156802662022200917110102.
5
COVID-19 will further exacerbate global antimicrobial resistance.新型冠状病毒肺炎将进一步加剧全球抗菌药物耐药性。
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa098.
6
Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.由于抗生素的非特异性使用导致对新冠病毒感染合并感染的低估。
J Infect. 2020 Sep;81(3):e29-e30. doi: 10.1016/j.jinf.2020.06.077. Epub 2020 Jul 3.
7
COVID-19 pneumonia and the appropriate use of antibiotics.新型冠状病毒肺炎与抗生素的合理使用。
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. doi: 10.1016/S2214-109X(20)30444-7. Epub 2020 Nov 11.
8
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月，美国密歇根州底特律市，COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
9
Coinfections with SARS-CoV-2 and other respiratory pathogens.新型冠状病毒（SARS-CoV-2）与其他呼吸道病原体的合并感染。
Infect Control Hosp Epidemiol. 2020 Oct;41(10):1228-1229. doi: 10.1017/ice.2020.322. Epub 2020 Jul 3.
10
Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.2020 年 4 月至 5 月，新加坡 4 例 COVID-19 合并结核病患者。
Emerg Infect Dis. 2020 Nov;26(11):2764-2766. doi: 10.3201/eid2611.202752. Epub 2020 Jul 15.

引用本文的文献

1
The Impact of the COVID-19 Pandemic on Pediatric Microbial Resistance Patterns and Abandonment Rates in Western Romania-An Interdisciplinary Study.新冠疫情对罗马尼亚西部儿童微生物耐药模式及抗生素停用率的影响——一项跨学科研究
Antibiotics (Basel). 2025 Apr 16;14(4):411. doi: 10.3390/antibiotics14040411.
2
Activity of ceftolozane/tazobactam and comparators against gram-negative bacilli: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART - Brazil), 2018‒2021.头孢他啶/阿维巴坦及对照药物对革兰氏阴性杆菌的活性：2018 - 2021年巴西抗菌药物耐药性趋势监测研究（SMART - 巴西）结果
Braz J Infect Dis. 2025 Jan-Feb;29(1):104497. doi: 10.1016/j.bjid.2024.104497. Epub 2024 Dec 12.
3

本文引用的文献

1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
3
Impact of COVID-19 on Antibiotic Stewardship, Antimicrobial Resistance, and Prescribing Habits at Two General Hospitals in Abu Dhabi: A Retrospective Analysis.
新冠疫情对阿布扎比两家综合医院抗生素管理、抗菌药物耐药性及处方习惯的影响：一项回顾性分析
Cureus. 2024 Sep 11;16(9):e69170. doi: 10.7759/cureus.69170. eCollection 2024 Sep.
4
Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China.中国河南产碳青霉烯酶的革兰氏阴性菌的分布及分子特征。
Sci Rep. 2024 Jun 22;14(1):14418. doi: 10.1038/s41598-024-65106-0.
5
Antibacterial agents used in COVID-19: A systematic review and meta-analysis.用于新型冠状病毒肺炎的抗菌药物：一项系统评价与荟萃分析
Environ Sustain (Singap). 2021;4(3):503-513. doi: 10.1007/s42398-021-00194-6. Epub 2021 Jun 7.
6
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world.合并感染与抗微生物药物耐药性与严重急性呼吸综合征冠状病毒2感染：新冠疫情后世界的困境。
Case Stud Chem Environ Eng. 2021 Jun;3:100093. doi: 10.1016/j.cscee.2021.100093. Epub 2021 Feb 21.
7
The Rapidly Changing Patterns in Bacterial Co-Infections Reveal Peaks in Limited Gram Negatives during COVID-19 and Their Sharp Drop Post-Vaccination, Implying Potential Evolution of Co-Protection during Vaccine-Virus-Bacterial Interplay.细菌合并感染模式的快速变化揭示了 COVID-19 期间有限的革兰氏阴性菌的峰值及其接种疫苗后的急剧下降，这意味着在疫苗-病毒-细菌相互作用期间，合并保护可能会发生进化。
Viruses. 2024 Jan 31;16(2):227. doi: 10.3390/v16020227.
8
How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?新冠疫情如何影响巴西的抗菌药物消费和细菌耐药情况？
Antibiotics (Basel). 2023 Aug 28;12(9):1374. doi: 10.3390/antibiotics12091374.
9
Gram-negative bacilli carrying mcr gene in Brazil: a pathogen on the rise.巴西携带 mcr 基因的革兰氏阴性杆菌：一种上升的病原体。
Braz J Microbiol. 2023 Jun;54(2):1009-1020. doi: 10.1007/s42770-023-00948-w. Epub 2023 Mar 21.
10
Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications.巴基斯坦不同医院在新冠疫情期间抗菌药物使用情况的现况调查：结果与启示
Antibiotics (Basel). 2022 Dec 30;12(1):70. doi: 10.3390/antibiotics12010070.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
4
Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits.儿科直接面向消费者的远程医疗就诊期间的抗生素处方。
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2018-2491. Epub 2019 Apr 8.
5
Multi-hospital point prevalence study of healthcare-associated infections in 28 adult intensive care units in Brazil.巴西 28 家成人重症监护病房的多医院点患病率研究：与医疗保健相关的感染。
J Hosp Infect. 2018 Jul;99(3):318-324. doi: 10.1016/j.jhin.2018.03.003. Epub 2018 Mar 6.